Results: 3

1.
Fig 1

Fig 1. From: Endovascular Treatment of Medically Refractory Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.

Selection of the study population from July 2003 to January 2008.

P. Jun, et al. AJNR Am J Neuroradiol. ;31(10):1911-1916.
2.
Fig 2

Fig 2. From: Endovascular Treatment of Medically Refractory Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.

Longitudinal clinical outcomes. Differences between good (HH scores, 1–3) and poor (HH scores, 4 and 5) clinical presentation groups are significantly different for all outcome measures (χ2 = 32, df = 2, P < .001).

P. Jun, et al. AJNR Am J Neuroradiol. ;31(10):1911-1916.
3.
Fig 3

Fig 3. From: Endovascular Treatment of Medically Refractory Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.

IA verapamil dose by CV severity. Only IA infusions into the ICA and vertebral arteries are considered (n = 680, 94% of total vessel segments infused). X indicates the median verapamil dose.

P. Jun, et al. AJNR Am J Neuroradiol. ;31(10):1911-1916.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk